Estimation of Chloride Channel Residual Function and Assessment of Targeted Drugs Efficiency in the Presence of a Complex Allele [L467F;F508del] in the CFTR Gene
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910424 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anna Efremova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, Moskvorechye Str. 1, 115522 Moscow, Russia. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis, Alleles, Aminophenols. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Complex alleles of the CFTR gene complicate the diagnosis of cystic fibrosis (CF), the classification of its pathogenic variants, affect the clinical picture of the disease and can affect the efficiency of targeted drugs. The total frequency of complex allele [L467F;F508del] in the Russian population of patients with CF is 0.74%, and in patients with the F508del/F508del genotype, its frequency reaches 8%. This article presents multi-faceted study of the complex allele [L467F;F508del] in a cohort of patients with genotypes [L467F;F508del]/class I (c.3532_3535dup, c.1766+2T>C, W1310X, 712-1G>T), and data for a unique patient with the genotype [L467F;F508del]/[L467F;F508del]. Using the intestinal current measurement method, it was demonstrated the absence of CFTR function for [L467F;F508del]/class I and [L467F;F508del]/[L467F;F508del] genotypes. In intestinal organoids, it was shown that [L467F;F508del] in combination with class I variants and in the homozygotes abolishes the efficacy of both two-component (ivacaftor+lumacaftor; ivacaftor+tezacaftor) and three-component (ivacaftor+tezacaftor+elexacaftor) targeted drugs. When prescribing ivacaftor+tezacaftor+elexacaftor to three patients, they did not have a clinical effect after 6–12 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Centre for Medical Genetics, Moskvorechye Str. 1, 115522 Moscow, Russia.
ORCID-Profile: Yuliya Melyanovskaya, Tatiana Bukharova, Elena Kondratyeva
Förderung
- Russian Science Foundation
Zitieren
APA
Efremova, A., Melyanovskaya, Y., Krasnova, M., Voronkova, A., Mokrousova, D., Zhekaite, E., Bulatenko, N., Makhnach, O., Bukharova, T., Kutsev, S., Goldshtein, D., & Kondratyeva, E. (2024). Estimation of Chloride Channel Residual Function and Assessment of Targeted Drugs Efficiency in the Presence of a Complex Allele [L467F;F508del] in the CFTR Gene. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910424
Vancouver
Efremova A, Melyanovskaya Y, Krasnova M, Voronkova A, Mokrousova D, Zhekaite E, et al. Estimation of Chloride Channel Residual Function and Assessment of Targeted Drugs Efficiency in the Presence of a Complex Allele [L467F;F508del] in the CFTR Gene. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910424
BibTeX
@article{Efremova2024,
author = {Efremova, Anna and Melyanovskaya, Yuliya and Krasnova, Maria and Voronkova, Anna and Mokrousova, Diana and Zhekaite, Elena and Bulatenko, Nataliya and Makhnach, Oleg and Bukharova, Tatiana and Kutsev, Sergei and Goldshtein, Dmitry and Kondratyeva, Elena},
title = {Estimation of Chloride Channel Residual Function and Assessment of Targeted Drugs Efficiency in the Presence of a Complex Allele [L467F;F508del] in the CFTR Gene},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910424}
}
EUVIMED